Applying genomics-related technologies for Africa's health needs.
While the past century has seen significant improvement in life expectancies in the developed world, it has also witnessed diseases like HIV/AIDS, malaria and tuberculosis ravage populations in the developing world. In some Sub-Saharan African countries, life expectancies have plummeted to less than 40 years--nearly half of those in developed countries. Unequal access to the benefits of science and technology, including medical advances, exacerbate this disparity. In order to address the challenge of global health inequities and strengthen the role of science and technology innovation in contributing to real solutions, the Canadian Program on Genomics and Global health (CPGGH), based at the University of Toronto, has identified three guiding questions: Which genomics-related technologies are most likely to improve the health of people in developing countries?; How can developing countries harness these technologies for health development?; and What can industrialized countries do to assist developing countries?
Singer
P A
PA
University of Toronto Joint Centre for Bioethics, Toronto, Canada. peter.singer@utoronto.ca
Court
E B
EB
Bhatt
A
A
Frew
S E
SE
Greenwood
H
H
Persad
D L
DL
Salamanca-Buentello
F
F
Séguin
B
B
Taylor
A D
AD
Daer
H T
HT
Daar
A S
AS
D000349:Africa; D017954:Africa South of the Sahara; D001709:Biotechnology / Q000458:organization & administration; D003906:Developing Countries; D023281:Genomics / Q000639:trends*; D014943:Global Health; D006301:Health Services Needs and Demand / Q000458:organization & administration*; D006801:Humans; D036103:Nanotechnology; D016730:Program Development; D013672:Technology; D018581:Technology Transfer